MedTrace Logo

Group CBT for Depression and AOD Disorders

NCT01154309 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 73

Last updated 2011-11-16

No results posted yet for this study

Summary

The investigators will adapt and test an existing treatment (group CBT for depression) for use in outpatient substance use treatment settings as delivered by trained substance use counselors. The investigators expect that treatment will lead to improved depression and substance use outcomes.

Conditions

Interventions

BEHAVIORAL

Group CBT for Depression and AOD Disorders

18 sessions of 2-hour group CBT

Sponsors & Collaborators

  • Behavioral Health Services, Inc.

    collaborator INDUSTRY

  • RAND

    lead OTHER

Principal Investigators

  • Katherine E Watkins, MD, MSHS · RAND

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2009-09-30
Completion
2009-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01154309 on ClinicalTrials.gov